Page last updated: 2024-10-21

4-iodo-2,5-dimethoxyphenylisopropylamine and Brain Neoplasms

4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Brain Neoplasms in 1 studies

4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garcia, MC1
Kim, KY1
Hough, C1
Kim, HY1

Other Studies

1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Brain Neoplasms

ArticleYear
Effects of chronic ethanol on the mobilization of arachidonate and docosahexaenoate stimulated by the type 2A serotonin receptor agonist (+/-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride in C6 glioma cells.
    Alcoholism, clinical and experimental research, 1997, Volume: 21, Issue:8

    Topics: Amphetamines; Animals; Arachidonic Acid; Astrocytes; Brain Neoplasms; Cell Survival; Docosahexaenoic

1997